Granules India informs about press release

03 Jul 2020 Evaluate

Granules India has informed that the Company enclosed the press release given by Granules Pharmaceuticals, Inc., a wholly owned subsidiary of the Company titled: ‘Granules Pharmaceuticals, Inc. issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

574.50 9.50 (1.68%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×